Oncotarget£ºË¥ÀϹý³ÌÁ×Ö¬×÷ÓÃлúÖÆ
´óÄÔ½«´ó²¿·ÖÄÜÁ¿ÓÃÓÚά³ÖĤ֬¶¯Á¦Ñ§£¬ÒÔ±£Ö¤°üÀ¨Á×Ö¬ºÍÇÊÁ×Ö¬ÔÚÄڵĸ÷ÖÖĤ֬µÄÖ¬·¾õ£»ù×é³ÉµÄÌØÒìÐÔ¡£Òò´Ë£¬²»Í¬Ä¤Ö¬µÄÖ¬·¾õ£»ùÑϸñµÄÒìÖÊÐÔ¶ÔÓÚά»¤Ä¤Ö¬ÍêÕûºÍ´óÄÔµÄÕý³£ÔË×÷¼«ÆäÖØÒª¡£ºãºÓºïÓÉÓÚÓëÈËÀà»ùÒòµÄ¸ß¶ÈͬԴÐÔ£¨Ô¼92.5£¥ÖÁ95£¥£©£¬ÔÚÄêÁäÏà¹Ø±íÐÍÉÏ»á±íÏÖ³ö¸ß¶ÈÀàËÆµÄÕý³£Ë¥ÀÏ״̬¡£¾¡¹ÜÒÑÓдóÁ¿Ñо¿¹¤×÷ÖÂÁ¦ÓÚ½Òʾ¶à²»±¥ºÍÖ¬·¾ËᣨpUFAs£©ÔÚÉñ¾²¡Ñ§É϶ÔÈËÄÔË¥ÀϵÄÓ°Ï죬Èô¸ÉÁÙ´²Ñо¿Ò²Çå³þ²ûÊöÁËÔÚÈËÀàÕý³£Ë¥ÀϹý³ÌÖжþÊ®¶þ̼ÁùÏ©ËᣨDHAs£©ÎÈ̬µÄ¶¯Ì¬±ä»¯£¬µ«ÔÚ¶¯Îï»òÌåÍâÑо¿ÖÐûÓй۲쵽ÏàËÆµÄ±ä»¯¡£È±·¦ºÏÊʵ͝ÎïÄ£ÐÍÒÔ¼°ÈËÄÔ×éÖ¯Ñо¿µÄÂ×ÀíÔ¼ÊøÔںܴó³Ì¶ÈÉÏÏÞÖÆÁËpUFAÓë´óÄÔµÄÑо¿¡£
Öйú¿ÆÑ§ÔºÒÅ´«Óë·¢ÓýÉúÎïѧÑо¿Ëù˰¹âºñÑо¿×éÔËÓÃÇ°ÑØÖ¬×éѧ¼¼Êõ£¬±¨µÀÁËÈý¸ö²»Í¬ÄêÁä½×¶Î£¨Ó×Äê¡¢³ÉÄêºÍÀÏÄ꣩ºãºÓºïµÄǰ¶îÒ¶×éÖ¯ÖÐĤ֬±ä»¯¾ßÌåµ½¸÷ÖÖÖ¬·¾õ£µÄÖ¬ÎÆÆ×¡£Í¨¹ý¶ÔºãºÓºïµÄǰ¶îҶĤ֬֬·¾õ£»ùרÏî·ÖÎöÓÐÁ¦µØÖ¤Ã÷ºãºÓºïÊÇÒ»¸öºÏÊÊ×÷ΪÑо¿ÈËÀà´óÄÔÕý³£Ë¥ÀϵÄÄ£ÐÍ£¬ÓÈÆäÊÇÔڶ಻±¥ºÍÖ¬·¾Ëá´úл·½Ãæ¡£ÖµµÃ×¢ÒâµÄÊÇ£¬Ö¬×éѧ·ÖÎöÏÔʾÁ×Ö¬ÖÐpUFAËæÄêÁäµÄ·Ö²¼±ä»¯£»¶ø¶þÊ®¶þ̼ÁùÏ©ËᣨDHAs£©ÔÚ³ÉÄêºãºÓºïËùÓмì²â³öµÄÖ¬ÀàÖж¼ÏÔÖøÔö¼Ó£¬¶ø¸ÃÖÖÔö¼Ó½öÏÞÓÚDHA£¬ÆäËû¶à±¥ºÍÖ¬·¾ËᣨpUFAs£©È´ÎÞ´ËÏÖÏó¡£ÁíÒ»·½Ã棬»¨ÉúËÄÏ©ËᣨARA£©ÔÚ³ÉÄêºãºÓºïĤ֬Öм±¾ç¼õÉÙ£¬ÆäÖÐÖ»ÓÐÐÄÁ×Ö¬£¨CL£©¸ÃÖֱ仯ÓÐËù¼õÈõ¡£ÓÐȤµÄÊÇ£¬ÔÚÀÏÄêºãºÓºïÖи»º¬DHAµÄÁ×Ö¬¼õÉÙ¶ø³¬³¤Á´ÇÊÁ×Ö¬£¨VLC-SMs£©È´Ôö¼Ó£¬Ïà¹ØÐÔ·ÖÎöÖ¤ÊµËæ×ÅÄêÁäµÄÔö³¤Ä¤Ö¬µÄ¹ØÁªµ÷¿Ø³Ì¶È»á²»¶Ï¼ÓÉî¡£ÓÈÆäÊÇÀÏÄêºãºÓºï£¬ÐÄÁ×Ö¬Ó븻º¬pUFAµÄÁ×Ö¬³ÊÏÖÕýÏà¹Øµ÷¿Ø£¬¶ø¸»º¬DHAµÄÁ×Ö¬Ó볬³¤Á´ÇÊÁ×Ö¬³ÊÏÖ¸ºÏà¹Øµ÷¿Ø¡£Òò´Ë£¬Ö¬×éѧÊý¾Ý½ÒʾһÖÖÖµµÃ×¢ÒâµÄ¿ÉÄÜÐÔ£ºÔÚÉñ¾Ä¤Éϸ»º¬DHAµÄÄ¤Î¢ÇøºÍ¸»º¬ÇÊÁ×Ö¬/µ¨¹Ì´¼µÄĤ·¤¿ÉÄÜ´æÔÚן´ÔÓµÄʱ¼äÏ໥×÷Óá£
Ö¬ÖʹØÁªµ÷¿Ø·ÖÎöÒ²±íÃ÷ËæÄêÁ书ÄÜÄ¤Î¢Çø×ª»»£¨Óɸ»º¬DHAµÄÄ¤Î¢Çø×ª±äΪ¸»º¬ÇÊÁ×Ö¬/µ¨¹Ì´¼Ö¬·¤£©»á¸Ä±äCLÖØ¹¹µÄЧÂÊ£¬´Ó¶øµ¼ÖÂÐÄÁ×Ö¬º¬Á¿Öð½¥¼õÉÙ£¬Í¨¹ýÏßÁ£ÌåÑõ»¯Á×ËữµÄÄÜÁ¿¹©Ó¦¼õÉÙ¡£Ëæ×ÅÄÜÁ¿¹©¸ø¼õÉÙºÍÄ¤ÍØÆË½á¹¹µÄ¸Ä±ä»áÆô¶¯Ìæ´úµÄÁ×Ö¬ºÏ³Éͨ·£¬È¡´úά³ÖĤ¶¯Ì¬µÄ´ÓÍ·ºÏ³Éͨ·ÒÔ¼õÉÙÄÜÁ¿ÏûºÄ£¬ÕâÒ²¿ÉÒÔ½âÊÍÔÚÀÏÄêºãºÓºïÖжÀÌØµÄĤ֬¹ØÁªµ÷¿Ø¡£¸ù¾ÝÕâÒ»ÀíÂÛ£¬Òý·¢´óÄÔË¥ÀϵĹؼü½Úµã±¾ÖÊÉÏÒ²ÐíÊÇÎÞ·¨Î¬³ÖÉñ¾Ä¤Ö¬ÖÐDHAµÄ¸ßˮƽ¡£´ËÍ⣬ÔÚÀÏÄêºãºÓºïÖÐLpC-22:6ºÍLpE-22:6Ó뺬ÓÐDHAÁ×Ö¬Ö®¼äÎÞ¹ØÁªµ÷¿Ø°µÊ¾Ôì³É¸»º¬DHAÁ×Ö¬¼õÉÙµÄÖ÷ÒªÔÒòÊÇÎÞ·¨½«º¬ÓÐDHAµÄÈÜѪÁ×֬ת»»Îª¶ÔӦĤ֬£¬¶ø²»ÊÇÎÞ·¨ÌṩÄÜ¿ç¹ýѪÄÔÆÁÕϸ»º¬DHAµÄÈÜѪÁ×Ö¬¡£ÖµµÃ×¢ÒâµÄÊÇ£¬Õâ¸ö»úÖÆÍÆ²âÓëÁÙ´²¹Û²ìÏà·ûºÏ£ºDHAÒûʳ²¹³ä¿ÉÓÐЧ×èÖ¹»òÑÓ»ºÉñ¾ÍËÐÐÐÔ¼²²¡·¢²¡È´¶ÔÈ·ÕïµÄ°¢¶û´Äº£Ä¬Ö¢µÄÖÎÁÆÃ»ÓÐЧ¹û¡£Õâ˵Ã÷Éñ¾Ä¤Ö¬ÖÐDHAÏÔÖøÏ½µÎ£º¦Ò²ÐíԶʤÓÚʳÎïÖÐDHA¹©¸ø±¾ÉíµÄ¼õÉÙ¡£
Ïà¹ØÑо¿½á¹ûÓÚ8ÔÂ10ÈÕÔÚÏß·¢±íÓÚOncotarget ÔÓÖ¾£¨DOI: 10.18632/oncotarget.11190£©¡£Ë°¹âºñÑо¿×鲩ʿºóSin Man LamΪ¸ÃÂÛÎĵĵÚÒ»×÷Õߣ¬Ë°¹âºñΪ¸ÃÂÛÎĵÄͨѶ×÷Õß¡£¸ÃÏîÄ¿µÃµ½ÁËÖпÆÔº¡°****¡±¡¢¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»áÏîÄ¿¡¢Öйú²©Ê¿ºóÌØ±ð»ù½ðÏîÄ¿µÄ×ÊÖú¡£
